Skip to main content

Inspection visit

Health inspection

HAWTHORNE CENTER FOR REHABILITATION AND HEALING OFCMS #1056021 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0658 Ensure services provided by the nursing facility meet professional standards of quality. Level of Harm - Minimal harm or potential for actual harm **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, the facility failed to administer medications in accordance with professional standards of practice for 3 of 3 residents reviewed for medication administration, Residents #6, #7 and #8. Residents Affected - Some Findings include: 1. Review of Resident #6's admission record revealed the resident was admitted with the diagnoses including nontraumatic acute subdural hemorrhage (bleeding in the brain), nontraumatic chronic subdural hemorrhage, pneumonia, seizures, dementia, essential primary hypertension, anxiety disorder, and major depression. Review of Resident #6's physician order dated 11/10/2023 reads, Amlodipine Besylate oral tablet 10 milligrams give one tablet by mouth one time a day related to essential primary hypertension hold for systolic BP [blood pressure] less than 110 and or heart rate less than 60. Review of Resident #6's physician order dated 11/10/2023 reads, Lisinopril oral tablet 10 milligrams give one tablet by mouth one time a day related to essential primary hypertension hold for systolic BP less than 110 and heart rate less than 60. Review of Resident #6's physician order dated 11/10/2023 reads, Levetiracetam oral tablet (Keppra) 500 mg [milligrams] give 1 tablet by mouth two times a day. Review of Resident #6's physician order dated 11/10/2023 reads, Doxycycline Hyclate 100 mg, give 100 mg by mouth every 12 hours for pneumonia for 6 days until finished. Review of Resident #6's Medication Administration Record for November 2023 for administration of Levetiracetam oral tablet (Keppra) 500 mg showed the medication was administered on 11/12/2023 at 12:37 AM (scheduled for 11/11/2023 at 9:00 PM), on 11/13/2023 at 12:49 PM (scheduled for 9:00 AM); on 11/14/2023 at 10:54 PM (scheduled for 9:00 PM); on 11/16/2023 at 3:31 PM (scheduled for 9:00 AM); on 11/17/2023 at 7:27 PM (scheduled for 9:00 AM); on 11/18/2023 at 12:31 AM (scheduled for 11/17/2023 at 9:00 PM); on 11/18/2023 at 11:22 AM (scheduled for 9:00 AM); on 11/19/2023 at 12:25 PM (scheduled for 9:00 AM); on 11/20/2023 at 10:46 PM (scheduled for 9:00 PM); on 11/22/2023 at 11:23 AM (scheduled for 9:00 AM); on 11/23/2023 at 1:18 PM (scheduled for 9:00 AM); on 11/24/2023 at 6:33 PM (scheduled for 9:00 AM) and at 11:21 PM (scheduled for 9:00 PM); on 11/27/2023 at 10:36 AM (scheduled for 9:00 AM); on 11/29/2023 at 11:22 AM (scheduled for 9:00 AM); and on 11/30/2023 at 10:18 PM (scheduled for 9:00 AM). Review of Resident #6's Medication Administration Record for November 2023 for administration of (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 4 Event ID: 105602 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 105602 B. Wing A. Building (X3) DATE SURVEY COMPLETED 12/01/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Hawthorne Center for Rehabilitation and Healing Of 4100 SW 33rd Ave Ocala, FL 34474 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Amlodipine Besylate oral tablet 10 mg showed the medication was administered on 11/18/2023 at 11:22 AM (scheduled for 9:00 AM); on 11/19/2023 at 12:25 PM (scheduled for 9:00 AM); on 11/22/2023 at 11:23 AM (scheduled for 9:00 AM); on 11/23/2023 at 1:18 PM (scheduled for 9:00 AM); on 11/24/2023 at 6:33 PM (scheduled for 9:00 AM); on 11/26/2023 at 10:57 AM (scheduled for 9:00 AM); on 11/27/2023 at 10:36 AM (scheduled for 9:00 AM); on 11/29/2023 at 11:22 AM (scheduled for 9:00 AM); and on 11/30/2023 at 10:18 PM (scheduled for 9:00 AM). Review of Resident #6's Medication Administration Record for November 2023 for administration of Lisinopril oral tablet 10 mg showed the medication was administered on 11/18/2023 at 11:22 AM (scheduled for 9:00 AM); on 11/19/2023 at 12:25 PM (scheduled for 9:00 AM); on 11/22/2023 at 11:23 AM (scheduled for 9:00 AM); on 11/23/2023 at 1:18 PM (scheduled for 9:00 AM); on 11/24/2023 at 6:33 PM (scheduled for 9:00 AM); on 11/26/2023 at 10:57 AM (scheduled for 9:00 AM); on 11/27/2023 at 10:36 AM (scheduled for 9:00 AM); on 11/29/2023 at 11:22 AM (scheduled for 9:00 AM); and on 11/30/2023 at 10:18 PM (scheduled for 9:00 AM). Review of Resident #6's Medication Administration Record for November 2023 for administration of Doxycycline Hyclate 100 mg showed the medication was administered on 11/16/2023 at 3:31 PM (scheduled for 9:00 AM). 2. Review of Resident #7's admission record revealed the resident was admitted with the diagnoses including Parkinson's disease, Alzheimer's disease with late onset, unspecified systolic congestive heart failure, atherosclerotic heart disease of native coronary artery with unspecified angina pectoris, cardiomegaly, hyperlipidemia, presence of cardiac and vascular implant and graft, bilateral cataracts, peripheral vascular disease, personal history of COVID-19, right knee contracture, left knee contracture, major depressive disorder, essential primary hypertension, chronic atrial fibrillation, anxiety disorder, age-related osteoporosis, and unspecified osteoarthritis. Review of Resident #7's physician order dated 10/9/2023 reads, Sotalol HCL [hydrochloride] tablet 160 milligrams give one tablet by mouth one time a day for hypertension hold for systolic BP less than 110 and or heart rate less than 60. Review of Resident #7's physician order dated 11/6/2023 reads, Eliquis 2.5 milligrams give one tablet by mouth two times a day for DVT [deep vein thrombosis] prophylaxis related to chronic atrial fibrillation. Review of Resident #7's physician order dated 11/6/2023 reads, Nuplazid oral capsule 34 milligrams give one capsule by mouth one time a day for psychosis. Review of Resident #7's physician order dated 11/6/2023 reads, Potassium chloride oral solution 20 [NAME] [milliequivalents]/15 ml [milliliters] give 7.5 ml by mouth one time a day for supplement. Review of Resident #7's physician order dated 11/17/2023 reads, Carbidopa Levodopa oral tablet 25-100 mg [milligram] give one tablet sublingually two times a day for Parkinson. Review of Resident #7's Medication Administration Record for November 2023 for administration of Eliquis tablet 2.5 mg showed the medication was administered on 11/8/2023 at 2:26 PM (scheduled for 9:00 AM); on 11/8/2023 at 6:56 PM (scheduled for 5:00 PM); on 11/9/2023 at 3:06 PM (scheduled for 9:00 AM); and on 11/9/2023 at 6:20 PM (scheduled for 5:00 PM). (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 105602 If continuation sheet Page 2 of 4 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 105602 B. Wing A. Building (X3) DATE SURVEY COMPLETED 12/01/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Hawthorne Center for Rehabilitation and Healing Of 4100 SW 33rd Ave Ocala, FL 34474 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Review of Resident #7's Medication Administration Record for November 2023 for administration of Carbidopa Levodopa oral tablet 25-100 mg showed the medication was administered on 11/8/2023 at 2:26 PM (scheduled for 11:30 AM); on 11/8/2023 at 6:56 PM (scheduled for 4:00 PM); and on 11/9/2023 at 3:06 PM (scheduled for 11:30 AM). Review of Resident #7's Medication Administration Record for November 2023 for administration of Potassium chloride oral solution showed the medication was administered on 11/9/2023 at 3:06 PM (scheduled for 9:00 AM). Review of Resident #7's Medication Administration Record for November 2023 for administration of Sotalol HCL tablet 160 mg showed the medication was administered on 11/9/2023 at 3:06 PM (scheduled for 9:00 AM). Review of Resident #7's Medication Administration Record for November 2023 for administration of Nuplazid oral capsule 34 mg showed the medication was administered on 11/9/2023 at 3:06 PM (scheduled for 9:00 AM). 3. Review of Resident #8's admission record revealed the resident was admitted with the diagnoses including type 2 diabetes mellitus with hyperglycemia, chronic obstructive pulmonary disease, hyperlipidemia, hypothyroidism, anxiety disorder, rheumatoid arthritis, mild protein calorie malnutrition, atherosclerotic heart disease of native coronary artery without angina pectoris, unspecified psychosis, adult failure to thrive, psoriasis, old myocardial infarction, and essential primary hypertension. Review of Resident #8's physician order dated 10/20/23 reads, Amlodipine Besylate oral tablet 10 milligrams give one tablet by mouth one time a day for hypertension. Review of Resident #8's physician order dated 10/20/2023, Biotin oral tablet 10 milligrams give one tablet by mouth one time a day for supplement. Review of Resident #8's physician order dated 10/20/2023 reads, Buspirone HCL oral tablet 10 milligrams give two tablet by mouth two times a day for anxiety. Review of Resident #8's physician order dated 10/20/2023 reads, Lamictal oral tablet 200 milligrams give one tablet by mouth one time a day for anticonvulsant. Review of Resident #8's physician order dated 10/20/2023 reads, Maxzide 25 milligrams 37.5 25 milligrams give one tablet by mouth one time a day for hypertension. Review of Resident #8's physician order dated 10/20/2023 reads, Pilocarpine HCL oral tablet 5 milligrams give one tablet by mouth four times a day for glaucoma. Review of Resident #8's physician order dated 10/20/2023 reads, Zoloft oral tablet 50 milligrams give four tablet by mouth one time a day for depression. Review of Resident #8's physician order dated 11/8/2023 reads, Fibercon oral tablet give one tablet by mouth two times a day for Constipation. Review of Resident #8's physician order dated 11/13/2023, reads, B12 fast dissolve oral tablet (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 105602 If continuation sheet Page 3 of 4 Printed: 05/28/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 105602 B. Wing A. Building (X3) DATE SURVEY COMPLETED 12/01/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Hawthorne Center for Rehabilitation and Healing Of 4100 SW 33rd Ave Ocala, FL 34474 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658 disintegrating 5000 MCG [micrograms] give one tablet by mouth one time a day for supplement. Level of Harm - Minimal harm or potential for actual harm Review of Resident #8's physician order dated 11/13/2023 reads, Vitamin D3 oral tablets 125 MCG give one tablet by mouth in the morning for supplement. Residents Affected - Some Review of Resident #8's physician order dated 11/21/2023 reads, Claritin oral tablet 10 milligrams give one tablet by mouth one time a day for allergies. Review of Resident #8's Medication Administration Record for November 2023 showed on 11/24/2023, Lamictal oral tablet, Claritin oral tablet, Vitamin D3 oral tablet, B12 fast dissolve oral tablet, Biotin oral tablet, Maxzide 25 oral tablet, and Buspirone HCL oral tablet were administered at 3:24 PM (all scheduled for 9:00 AM); on 11/24/2023, Gabapentin capsule was administered at 3:25 PM (scheduled for 2:00 PM); on 11/29/2023, B12 fast dissolve oral tablet, Buspirone HCL oral tablet, Fibercon oral tablet, Vitamin D3 oral tablet, Lamictal oral tablet, Maxzide 25 oral tablet, Zoloft tablet, Pilocarpine HCL tablet were administered at 11:24 AM (scheduled for 9:00 AM); on 11/30/2023, Buspirone HCL, Vitamin D3 oral tablet, Maxzide 25 oral tablet, Lamictal oral tablet, Zoloft oral tablet, Pilocarpine HCL oral tablet, Claritin oral tablet, Amlodipine Besylate oral tablet, Biotin oral tablet were administered 10:19 PM (scheduled for 9:00 AM); on 11/30/2023, Pilocarpine HCL oral tablet was administered at 10:19 PM (scheduled for 1:00 PM); and on 11/30/2023, Gabapentin oral capsule was administered at 10:20 PM (scheduled for 2:00 PM). During an interview on 12/1/2023 at 11:30 AM, the Director of Nursing (DON) stated, The standard is that medications are administered within 2 hours. I was not aware that medications were not administered or documented as administered per our policies and I do expect nurses to administer medications and document as soon as they are given. This is a standard. There are medications which must be given on time and they should be administered on time. During an interview on 12/1/2023 at 5:30 PM, Staff A, Licensed Practical Nurse (LPN), stated, I should document that I have given my medications as soon as I do it. I sometimes forget and don't until the end of my shift. I have given medications late sometimes. I can't tell you exactly when I did that. I should not document them at the end of my shift. All medications should be administered within 2 hours of when they are due. I think that I am able to get my work done most of the time. I just help the residents and sometimes my computer logs out. I think that's how that happened. I should administer the medications with an hour of them due. Review of the facility policy and procedure titled Medications, oral reads, Reporting and Documentation: The following should be reported to the staff/charge nurse and should be documented in the resident's medical record: 1. The drug name, dose, time, date and route of administration. (Note: Such information should be documented on the resident's medication administration record immediately after the drug is given). FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 105602 If continuation sheet Page 4 of 4

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0658GeneralS&S Epotential for harm

    F658 - Comprehensive Care Plans

    Ensure services provided by the nursing facility meet professional standards of quality.

FAQ · About this visit

Common questions about this visit

What happened during the December 1, 2023 survey of HAWTHORNE CENTER FOR REHABILITATION AND HEALING OF?

This was a inspection survey of HAWTHORNE CENTER FOR REHABILITATION AND HEALING OF on December 1, 2023. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at HAWTHORNE CENTER FOR REHABILITATION AND HEALING OF on December 1, 2023?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Ensure services provided by the nursing facility meet professional standards of quality."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.